Compare CPRX & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPRX | LION |
|---|---|---|
| Founded | 2002 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.4B |
| IPO Year | 2006 | 2025 |
| Metric | CPRX | LION |
|---|---|---|
| Price | $24.79 | $9.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $35.00 | $10.19 |
| AVG Volume (30 Days) | 897.2K | ★ 1.9M |
| Earning Date | 05-06-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.24 | N/A |
| EPS | ★ 1.68 | N/A |
| Revenue | $119,072,803.00 | ★ $3,195,500,000.00 |
| Revenue This Year | $9.20 | N/A |
| Revenue Next Year | $10.51 | $22.98 |
| P/E Ratio | $14.75 | ★ N/A |
| Revenue Growth | ★ 16.39 | 7.00 |
| 52 Week Low | $19.05 | $5.65 |
| 52 Week High | $26.56 | $11.02 |
| Indicator | CPRX | LION |
|---|---|---|
| Relative Strength Index (RSI) | 58.27 | 52.29 |
| Support Level | $22.24 | $6.46 |
| Resistance Level | $24.94 | $9.64 |
| Average True Range (ATR) | 0.66 | 0.34 |
| MACD | 0.18 | -0.05 |
| Stochastic Oscillator | 89.26 | 49.17 |
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.